CLINICAL EVENTS CALENDAR
Non-Accredited Education
 CLINICAL EXPERIENCE WITH A NEW HYBRID CORONARY WIRE On Demand Web ArchiveNon-Accredited Target Audience: Physicians, nurses, and technologists. This activity is supported by an educational grant from Terumo Medical Corporation. |
ORIGINAL CONTRIBUTIONS
Analysis of Right Radial Artery for Transradial Catheterization by Quantitative Angiography (FULL TITLE BELOW)
ABSTRACT: Objectives. To determine the optimal radial puncture point, we analyzed the anatomy and luminal diameter of the right radial artery (RA) by quantitative angiography. Background. Difficulty of radial puncture has impeded the establishment of the transradial approach as the standard procedure for cardiac catheterization. Methods. Antegrade angiography was performed from the right brachial artery in 135 patients who underwent coronary angiography. Presence and location of a bifurcation in the area of the RA puncture were analyzed. Furthermore, inner
Veno-Arterial ECMO in Severe Acute Right Ventricular Failure with Pulmonary Obstructive Hemodynamic Pattern
ABSTRACT: Extracorporeal membrane oxygenation (ECMO) is an effective rescue method for severe respiratory and cardiac failure. Right ventricular (RV) failure with cardiogenic shock is a critical condition with generally poor prognosis unless aggressive therapeutical measures are undertaken. Authors report on their initial experience with ECMO support in severe RV failure with cardiogenic shock caused by an obstructive hemodynamic pattern. Four patients with cardiogenic shock due to severe RV failure related to pulmonary arterial hypertension (2 patients), congeni
Video:
Use of a Percutaneous Left Ventricular Assist Device For High-Risk Cardiac Interventions and Cardiogenic Shock
ABSTRACT: Objective. We sought to describe the use of the TandemHeart percutaneous left ventricular assist device (PVAD) in a group of high-risk patients undergoing complex cardiovascular procedures. Background. There is a substantial risk of acute decompensation and death in patients with cardiogenic shock or a reduced cardiac reserve undergoing high-risk cardiovascular interventions. The TandemHeart PVAD provides near-total hemodynamic support in this setting. Methods. Thirty-seven high-risk patients underwent placement of the TandemHeart PVAD during 38 separate proc
Percutaneous Transluminal Dilatation of Inadvertent Partial or Complete Occlusion of the Femoral Artery (FULL TITLE BELOW)
FULL TITLE: Percutaneous Transluminal Dilatation of Inadvertent Partial or Complete Occlusion of the Femoral Artery Caused by Angio-Seal™ Deployment for Puncture Site Closure After Cardiac Catheterization
Comparison of Abciximab and Eptifibatide on Angiographic and Clinical Outcomes in (FULL TITLE BELOW)
TITLE: Comparison of Abciximab and Eptifibatide on Angiographic and Clinical Outcomes in Rescue Percutaneous Coronary Intervention for Failed Fibrinolytic Therapy
The Occlutech Figulla PFO and ASD Occluder: A New Nitinol Wire Mesh Device for Closure of Atrial Septal Defects
ABSTRACT: Background. We investigated the safety, feasibility and efficacy of the Occlutech® devices for patent foramen ovale (PFO) and atrial septal defect (ASD) closure in a prospective trial. Methods. The retention discs of the PFO device (23 x 25 mm, 27 x 30 mm) are connected by a 3 mm waist in the center with only one right atrial side central pin. The left atrial disc is produced either with a single or double flat layer, which allows a significant reduction of meshwork material. The ASD occluder (6–40 mm, 3 mm increments) has only one central pin on the right atrial sid
Vascular Complications after Percutaneous Coronary Intervention Following Hemostasis (see full title below)
Vascular Complications after Percutaneous Coronary Intervention Following Hemostasis with the Mynx Vascular Closure Device Versus the AngioSeal Vascular Closure Device
ABSTRACT: We investigated the prevalence of vascular complications after PCI following hemostasis in 190 patients (67% men and 33% women, mean age 64 years) treated with the AngioSeal vascular closure device (St. Jude Medical, Austin, Texas) versus 238 patients (67% men and 33% women, mean age 64 years) treated with the Mynx vascular closure device (AccessClosure, Mountain View, California). Results
Balloon Aortic Valvuloplasty for Severe Aortic Stenosis as a Bridge to High-Risk Transcatheter Aortic Valve Implantation
ABSTRACT: Objectives. To provide data on feasibility, safety and efficacy of balloon aortic valvuloplasty (BAV) as a bridge to trans-catheter aortic valve implantation (TAVI). Background. There are no data on BAV use as a bridge to TAVI in patients at high risk of peri-procedural complications. Methods. Between June 2007 to May 2009, 83 consecutive patients with symptomatic severe aortic stenosis (48 female, 35 male) aged from 65 to 88 years (mean age 81 ± 5 years) were treated with TAVI. Early hemodynamic and clinical outcomes of patients undergoing palliative BAV be
Drug-Eluting Stents versus Bare-Metal Stents in Acute ST-Segment Elevation Myocardial Infarction
Drug-Eluting Stents versus Bare-Metal Stents in Acute ST-Segment Elevation Myocardial Infarction. A Single-Center Experience with Long-Term Follow Up
ABSTRACT: Objectives. To compare the efficacy and safety of drug-eluting stents (DES) vs. bare-metal stents (BMS) in patients with acute ST-segment-elevation myocardial infarction (STEMI). Background. DES effectively reduce restenosis in elective percutaneous coronary intervention. Limited data are available about the use of DES in patients with STEMI. Methods. 453 consecutive patients who pres
Efficacy of Modified Dual Antiplatelet Therapy Combined with Warfarin Following Percutaneous (FULL TITLE BELOW)
ABSTRACT: Background. The optimal combination of anticoagulant and antiplatelet therapy following percutaneous coronary intervention with stenting (PCI-S) among patients requiring oral anticoagulation (OAC) is unknown. Objectives. We sought to compare the efficacy of a modified dual-antiplatelet regimen (daily aspirin and every other day clopidogrel) to conventional treatment (daily aspirin and daily clopidogrel) following percutaneous coronary intervention (PCI) with drug-eluting stents (DES) among patients who are also discharged on warfarin. Methods. We performed a single
Cardiology Blogs
All Subscriptions are FREE to qualified cardiology professionals
- Subscribe to:
- Journal
- Digital Journal
- E-News
- RSS feed
Anytown, California
Press Release
— Bethlehem, Pennsylvania – Invatec received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in October to market its Mo.Ma Ultra Proximal Cerebral Protection Device for use during carotid artery stenting (CAS). The device effectively reduces and captures debris released during the stenting procedure to prevent it from traveling to the brain, where it has the potential to cause a stroke.
CME Showcase
 The Use of Remote Robotic Navigation in Complex Arrhythmias Complimentary Accredited Web Archive This activity is designed for electrophysiologists and EP allied professionals. Diagnosing Coronary Artery Disease: Advanced Cardiovascular Imaging Solutions  New Standards of Care for CRMD Antibiotic Protection Complimentary CME Accredited Webcast Dates: November 18, 2008 Time: 6:00 pm ET November 19, 2008 Time: 3:00 pm ET This activity is sponsored by the North American Center for Continuing Medical Education. |
REVIEW OUR OTHER
CARDIOLOGY BRANDS Check out our other resources for healthcare professionals of all specialties.
